⚠️ Not Legal Advice

This page is for educational purposes only and does not constitute legal advice. Drug laws change frequently and vary by region within a country. Always verify the current status with ANVISA (Agência Nacional de Vigilância Sanitária), Brazil's national health surveillance agency (https://www.gov.br/anvisa/pt-br) or a qualified local lawyer before making any decisions. "Not explicitly illegal" is not the same as "legal." Brazil's gray-area status could change if ANVISA updates its schedules to explicitly include psilocybin mushrooms, as has happened in other countries.

Last reviewed: July 2026. This entry is drawn from Psilobase's broader Legal Status by Country guide. Because psilocybin law is an actively moving target worldwide, treat any date-stamped legal claim — including this one — as needing re-verification if you are reading it more than a few months after the review date above.

Quick Answer

Psilocybin mushrooms are not explicitly named in Brazil's controlled substances list (Portaria SVS/MS 344/98), which creates a genuine legal gray area rather than clear legality. In practice, mushrooms are rarely targeted by enforcement, and ceremonial/retreat use is widespread and largely tolerated, but this is not the same as a formal legalization.

Current Legal Status in Brazil

Because mushrooms are not explicitly listed, straightforward prosecution for simple possession is uncommon in practice. However, the isolated chemical compound psilocybin could theoretically be prosecuted under broader "analogue substance" provisions in Brazilian narcotics law, and enforcement discretion varies significantly by state and municipality. Retreat centers and ceremonial gatherings operate relatively openly, particularly in states such as Minas Gerais and parts of the Amazon region, but this reflects practical toleration rather than a codified legal right, and the position could shift with future regulatory action by ANVISA.

History: How the Law Got Here

Brazil's principal drug-scheduling regulation, Portaria SVS/MS 344/98 (as periodically updated by ANVISA, Brazil's health regulatory agency), lists psilocybin and psilocin as controlled substances by chemical name, but does not explicitly name Psilocybe mushrooms themselves. This gap — common in many countries' older drug schedules, which were often written before psychedelic mushrooms were widely used recreationally — has never been definitively closed by legislation or a landmark court ruling. Brazil's separate, well-established legal tradition around ayahuasca (a psychoactive brew used in registered religious contexts, protected by CONAD/federal rulings since the 1980s–2000s) has arguably normalized plant- and fungus-based ceremonial use in some regions, indirectly supporting tolerance of mushroom ceremonies, though the two substances have distinct legal histories and psilocybin mushrooms do not share ayahuasca's explicit religious-use legal protection.

How to Verify This Yourself

Laws referenced on this page were last reviewed in July 2026. Before making any decision based on legal status, check directly with ANVISA (Agência Nacional de Vigilância Sanitária), Brazil's national health surveillance agency: https://www.gov.br/anvisa/pt-br. For broader cross-country comparison and additional official sources (DEA, Home Office, Health Canada, TGA, EMCDDA, etc.), see the full Legal Status by Country guide.

Related Country Guides

Related Legal Topics